Published on May 12, 2025
MIRAMAR, Fla.,May 12, 2025/PRNewswire/ --Kimera Labs, Inc., the pioneer in therapeutic exosome biotechnology, is proud to announce its selection as a semifinalist in the prestigious$101 millionXPRIZE Healthspancompetition. This milestone recognizes Kimera's groundbreaking work in developing cutting-edge exosome-based therapeutics aimed at significantly extending the healthy, active years of human life.
The original XPRIZE, awarded in 2004, created a new model for solving big challenges in an open, incentive-based competition. By offering$10 millionfor private spaceflight, it sparked the commercial space industry and proved that bold goals, clear rules, and global participation could drive breakthrough innovation across any field.
Read More: Prnewswire.com/news-releases